Nuevos mecanismos de colaboración público-privada para el desarrollo y acceso a la vacuna COVID-19: Una perspectiva desde la teoría fundamentada
Por:
Jasso-Villazul J., Torres-Vargas A.
Publicada:
1 ene 2021
Categoría:
Business, management and accounting (miscellaneous)
Resumen:
The aim of this work is to identify and characterize how in the facing of a global event of high-impact, such as a pandemic, new forms of collaboration and competition among agents (companies, public research centers and universities, governments) emerge to accelerate the development of the vaccine to mitigate the pandemic of coronavirus disease 2019 (COVID-19). The text analyses the vaccine production process to face the SARS-CoV-2 coronavirus from the vaccine candidates that are in the stage of clinical studies of the most advanced phases by considering the characteristics of the agents, the countries to which they belong, the financing profile and the regulation features. The contribution of the work is to point out that in the development of the COVID-19 vaccine, new patterns of public-private collaboration have been promoted at the national and international level in multiple areas such as the scientific-technological, financial and regulatory. These patterns frame a new collaboration logic that could be an experience to solve global problems such as pandemics, with greater flexibility and speed. © 2020 Universidad Nacional Autonoma de Mexico. All rights reserved.
Filiaciones:
Jasso-Villazul J.:
Universidad Nacional Autónoma de México, Mexico
Torres-Vargas A.:
Universidad Autónoma Metropolitana, Mexico